Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Fig. 2

A. Progression free survival according to endocrine treatment in patients who take CDKi in first line. B. Progression free survival according to endocrine treatment in patients who take CDKi in second line. C. Progression free survival according to endocrine treatment in patients who take CDKi in ≥ 3rd line

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us